Zobrazeno 1 - 10
of 36
pro vyhledávání: '"E. Gonzalez Barca"'
Autor:
C. López, A. Rivas-Delgado, F. Nadeu, M. Grau, A. Rivero, J. Boschs-Schips, M. Alcoceba, G. Tapia, L. Luizaga, C. Bárcena, N. Kelleher, M. Pablo, O. Balague, G. Frigola, N. Villamor, L. Magnano, T. Baumann, A. Muntañola, J. M. Sancho-Cia, A. M. García-Sancho, E. Gonzalez Barca, F. Climent, E. Campo, E. Giné, A. López-Guillermo, S. Beà
Publikováno v:
HemaSphere, Vol 6, Pp 1162-1163 (2022)
Externí odkaz:
https://doaj.org/article/b4b87ea947bf4590ae2200081a3ab78b
Autor:
B. Navarro Matilla, P.L. Ortiz Romero, R.M. Pujol Vallverdú, A. Combalia Escudero, I. Zapata Paz, E. González Barca, C. Muniesa Montserrat, M. Morillo Andújar, A. Pérez Ferriols, C. Román Curto, R. Fernández de Misa Cabrera, M. Hospital Gil, A. Marín Niebla, P.J. Rios Rull, F. de la Cruz Vicente, R.M. Izu Belloso, A. Martín García-Sancho, M.E. Parera Amer, R. Córdoba Mascuñano, M.D. Ramón Quiles, A. Saus Carreres, R. del Campo García, S. Machan, P. Viguera Ester, J. Blanco Garnelo
Publikováno v:
Actas Dermo-Sifiliográficas, Vol 115, Iss 2, Pp 119-129 (2024)
Resumen: Antecedentes y objetivo: No se dispone de datos españoles sobre el coste asociado al linfoma cutáneo de células T (LCCT). Además, la incorporación de nuevos tratamientos hace necesario analizar el coste real de la enfermedad. El estudio
Externí odkaz:
https://doaj.org/article/6eae190ce75c4ed9b076e03f21cd9913
Autor:
J.J. Scarisbrick, P. Quaglino, H.M. Prince, E. Papadavid, E. Hodak, M. Bagot, O. Servitje, E. Berti, P. Ortiz‐Romero, R. Stadler, A. Patsatsi, R. Knobler, E. Guenova, F. Child, S. Whittaker, V. Nikolaou, C. Tomasini, I. Amitay, H. Prag Naveh, C. Ram‐Wolff, M Battistella, S. Alberti‐Violetti, R. Stranzenbach, V. Gargallo, C. Muniesa, T. Koletsa, C. Jonak, S. Porkert, C. Mitteldorf, T. Estrach, A. Combalia, M. Marschalko, J. Csomor, A. Szepesi, A. Cozzio, R. Dummer, N. Pimpinelli, V. Grandi, M. Beylot‐Barry, A. Pham‐Ledard, M. Wobser, E. Geissinger, U. Wehkamp, M. Weichenthal, R. Cowan, E. Parry, J. Harris, R. Wachsmuth, D. Turner, A. Bates, E. Healy, F. Trautinger, J. Latzka, J. Yoo, B. Vydianath, R. Amel‐Kashipaz, L. Marinos, A. Oikonomidi, A. Stratigos, M.‐D. Vignon‐Pennamen, M. Battistella, F. Climent, E. Gonzalez‐Barca, E. Georgiou, R. Senetta, P. Zinzani, L. Vakeva, A. Ranki, A.‐M. Busschots, E. Hauben, A. Bervoets, F.J.S.H. Woei‐A‐Jin, R. Matin, G. Collins, S. Weatherhead, J. Frew, M. Bayne, G. Dunnill, P. McKay, A. Arumainathan, R. Azurdia, K. Benstead, R. Twigger, K. Rieger, R. Brown, J.A. Sanches, D. Miyashiro, O. Akilov, S. McCann, H. Sahi, F.M. Damasco, C. Querfeld, A. Folkes, C. Bur, C.‐D. Klemke, P. Enz, R. Pujol, K. Quint, L. Geskin, E. Hong, F. Evison, M. Vermeer, L. Cerroni, W. Kempf, Y. Kim, R. Willemze
Publikováno v:
British journal of dermatology
Background Survival in mycosis fungoides (MF) is varied and may be poor. The PROCLIPI (PROspective Cutaneous Lymphoma International Prognostic Index) study is a web‐based data collection system for early‐stage MF with legal data‐sharing agreeme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d47836f6e5f7a5312eda8c97943f63f2
http://hdl.handle.net/2318/1717359
http://hdl.handle.net/2318/1717359
Autor:
B. Navarro Matilla, P.L. Ortiz Romero, R.M. Pujol Vallverdú, A. Combalia Escudero, I. Zapata Paz, E. González Barca, C. Muniesa Montserrat, M. Morillo Andújar, A. Pérez Ferriols, C. Román Curto, R. Fernández de Misa Cabrera, M. Hospital Gil, A. Marín Niebla, P.J. Rios Rull, F. de la Cruz Vicente, R.M. Izu Belloso, A. Martín García-Sancho, M.E. Parera Amer, R. Córdoba Mascuñano, M.D. Ramón Quiles, A. Saus Carreres, R. del Campo García, S. Machan, P. Viguera Ester, J. Blanco Garnelo
Publikováno v:
Actas Dermo-Sifiliográficas, Vol 115, Iss 2, Pp T119-T129 (2024)
Background and objective: The cost of treating cutaneous T-cell lymphoma (CTCL) in Spain is unknown. With the advent of new treatments, it is more important than ever to gain an accurate picture of the true costs involved. The MICADOS study had 2 pri
Externí odkaz:
https://doaj.org/article/e576240e183d4906976ebbc674ee547a
Autor:
S. Opat, C. Y. Cheah, M. Lasica, E. Verner, P. J. Browett, H. Chan, J. D. Soumerai, E. González Barca, J. Hilger, Y. Fang, J. Huang, D. Simpson, C. S. Tam
Publikováno v:
HemaSphere, Vol 6, Pp 583-584 (2022)
Externí odkaz:
https://doaj.org/article/ee700116e630435188d86e1555baa944
Autor:
Rivas-Delgado A; Department of Hematology Hospital Clínic Barcelona Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain., López C; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain.; Departament de Fonaments Clínics Universitat de Barcelona Barcelona Spain., Clot G; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain., Nadeu F; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain., Grau M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain., Frigola G; Department of Pathology, Hospital Clínic Hematopathology Section Barcelona Spain., Bosch-Schips J; Department of Pathology Hospital Universitari de Bellvitge, IDIBELL Hospitalet de Llobregat Spain., Radke J; Department of Neuropathology Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health Berlin Germany.; Institute of Pathology, Universitätsmedizin Greifswald Greifswald Germany., Ishaque N; Berlin Institute of Health (BIH) at Charité Universitätsmedizin Berlin, Center for Digital Health Berlin Germany., Alcoceba M; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain.; Department of Hematology Hospital Universitario de Salamanca, IBSAL Salamanca Spain.; Department of Hematology Centro de Investigación del Cáncer-IBMCC (USAL-CSIC) Salamanca Spain., Tapia G; Departments of Hematology and Pathology, Institut Català d'Oncologia Hospital Universitari Germans Trias i Pujol Badalona Spain.; Departament de Ciències Morfològiques Universitat Autònoma de Barcelona Barcelona Spain., Luizaga L; Departments of Hematology and Pathology Hospital Universitari Mutua de Terrassa Terrassa Spain., Barcena C; Departments of Hematology and Pathology Hospital Universitario 12 de Octubre Madrid Spain., Kelleher N; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Department of Hematology Institut Català d'Oncologia-Hospital Universitari de Girona Doctor Josep Trueta Girona Spain., Villamor N; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain.; Department of Pathology, Hospital Clínic Hematopathology Section Barcelona Spain., Baumann T; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Departments of Hematology and Pathology Hospital Universitario 12 de Octubre Madrid Spain., Muntañola A; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Departments of Hematology and Pathology Hospital Universitari Mutua de Terrassa Terrassa Spain., Sancho-Cia JM; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Departments of Hematology and Pathology, Institut Català d'Oncologia Hospital Universitari Germans Trias i Pujol Badalona Spain., García-Sancho AM; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain.; Department of Hematology Hospital Universitario de Salamanca, IBSAL Salamanca Spain.; Department of Hematology Centro de Investigación del Cáncer-IBMCC (USAL-CSIC) Salamanca Spain., Gonzalez-Barca E; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Departament de Fonaments Clínics Universitat de Barcelona Barcelona Spain.; Department of Hematology Institut Català d'Oncologia-Hospital Duran i Reynals, Hospitalet de Lobregat, IDIBELL Spain., Matutes E; Department of Pathology, Hospital Clínic Hematopathology Section Barcelona Spain., Brito JA; Department of Surgery Hospital Clínic Barcelona Spain., Karube K; Department of Pathology and Laboratory Medicine Nagoya University Hospital Nagoya Japan., Salaverria I; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain., Enjuanes A; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain., Wiemann S; Division of Molecular Genome Analysis German Cancer Research Center (DKFZ) Heidelberg Germany.; German Cancer Consortium (DKTK) Partner Site Charité Berlin Berlin Germany., Heppner FL; Department of Neuropathology Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health Berlin Germany.; German Cancer Consortium (DKTK) Partner Site Charité Berlin Berlin Germany., Siebert R; Institute of Human Genetics Ulm University & Ulm University Medical Center Ulm Germany., Climent F; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Department of Pathology Hospital Universitari de Bellvitge, IDIBELL Hospitalet de Llobregat Spain., Campo E; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain.; Departament de Fonaments Clínics Universitat de Barcelona Barcelona Spain.; Department of Pathology, Hospital Clínic Hematopathology Section Barcelona Spain., Giné E; Department of Hematology Hospital Clínic Barcelona Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain., López-Guillermo A; Department of Hematology Hospital Clínic Barcelona Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain.; Departament de Medicina Universitat de Barcelona Barcelona Spain., Beà S; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) Barcelona Spain.; Grupo Español de Linfomas y Trasplante de Médula Ósea (GELTAMO) Madrid Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Madrid Spain.; Departament de Fonaments Clínics Universitat de Barcelona Barcelona Spain.; Department of Pathology, Hospital Clínic Hematopathology Section Barcelona Spain.
Publikováno v:
HemaSphere [Hemasphere] 2024 Oct 07; Vol. 8 (10), pp. e70024. Date of Electronic Publication: 2024 Oct 07 (Print Publication: 2024).
Autor:
Gonzalez Barca E; Hematology Department, Catalan Institute of Oncology-IDIBELL, University of Barcelona, 08908 Barcelona, Spain.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2023 Nov 28; Vol. 12 (23). Date of Electronic Publication: 2023 Nov 28.
Autor:
Peña M; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Montané C; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Paviglianiti A; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Hurtado L; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain., González S; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain., Carro I; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Maluquer C; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Domingo-Domenech E; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain., Gonzalez-Barca E; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Bellvitge Health Sciences Campus, University of Barcelona, Barcelona, Spain., Sureda A; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain.; Bellvitge Health Sciences Campus, University of Barcelona, Barcelona, Spain., Mussetti A; Clinical Hematology Department, Institut Català d'Oncologia-Hospitalet, Barcelona, Spain. amussetti@iconcologia.net.; Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), Barcelona, Spain. amussetti@iconcologia.net.
Publikováno v:
Bone marrow transplantation [Bone Marrow Transplant] 2023 Nov; Vol. 58 (11), pp. 1282-1285. Date of Electronic Publication: 2023 Aug 25.
Autor:
Gonzalez Barca E; Hematology Department, Institut Català d'Oncologia Hospitalet, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Tomás-Roca L; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain., Esteve A; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Medical Oncology Department, B-ARGO Badalona, Catalan Institute of Oncology, Barcelona, Spain., Rodriguez M; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain., Gato L; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain., Alonso-Alonso R; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, Spain., Martin Garcia-Sancho A; Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain., Cordoba R; Hematology Department, Fundación Jiménez Díaz, Madrid, Spain., Monter-Rovira A; Hematology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Bastos-Oreiro M; Hematology Department, Gregorio Marañon General University Hospital, Madrid, Spain., Bergua Burgues JM; Hematology Department, Hospital San Pedro Alcántara, Caceres, Spain., Sayas MJ; Hematology Department, Hospital Universitario Dr. Peset, Valencia, Spain., Viguria Alegria MC; Hematology Department, Complejo Hospitalario de Navarra, Pamplona, Spain., Sanchez-Blanco JJ; Hematology Department, Hospital Morales Messeguer, Murcia, Spain., Roig Pellicer M; Hematology Department, Hospital La Fe, Valencia, Spain., Luzardo Henriquez HD; Hematology Department, Hospital Dr. Negrín, Las Palmas de Gran Canaria, Spain., de Oña R; Hematology Department, MD Anderson Cancer Center, Madrid, Spain., Cabezudo ME; Hematology Department, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain., Infante MS; Hematology Department, Hospital Infanta Leonor, Madrid, Spain., Queizán Hernández JA; Hematology Department, Hospital General de Segovia, Segovia, Spain., Sanz-Pamplona R; Unit of Biomarkers and Susceptibility, Oncology Data Analytics Program (ODAP), Catalan Institute of Oncology, Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL) and CIBERESP, Barcelona, Spain., Blanco O; Pathology Department, Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain., Mozos A; Pathology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Climent F; Pathology Department, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet De Llobregat, Barcelona, Spain., Piris MA; Pathology Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.
Publikováno v:
American journal of hematology [Am J Hematol] 2023 Jun; Vol. 98 (6), pp. E134-E138. Date of Electronic Publication: 2023 Mar 16.
Autor:
Frontzek F; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Staiger AM; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tübingen, Germany.; Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany., Zapukhlyak M; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Xu W; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Bonzheim I; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen-Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Borgmann V; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen-Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Sander P; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen-Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Baptista MJ; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Heming JN; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Berning P; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Wullenkord R; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Erdmann T; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Lutz M; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Veratti P; Department of Psychiatry and Psychotherapy, University Hospital Freiburg, Freiburg, Germany., Ehrenfeld S; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Wienand K; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Horn H; Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart and University of Tuebingen, Tübingen, Germany.; Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany., Goodlad JR; Department of Pathology, Queen Elizabeth University Hospital, Glasgow, United Kingdom., Wilson MR; Department of Haematology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Anagnostopoulos I; Institute of Pathology, University of Würzburg, Würzburg, Germany.; Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Lamping M; Charité Comprehensive Cancer Center, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany., Gonzalez-Barca E; Department of Hematology. ICO-Hospital Duran i Reynals, Universitat de Barcelona, L'Hospitalet de Llobregat, Llobregat, Spain., Climent F; Department of Pathology. Hospital Universitari de Bellvitge-IDIBELL, L'Hospitalet de Llobregat, Llobregat, Spain., Salar A; Department of Hematology, Hospital del Mar, Barcelona, Spain., Castellvi J; Department of Pathology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Abrisqueta P; Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Menarguez J; Department of Pathology, Hospital Gregorio Marañón, Madrid, Spain., Aldamiz T; Department of Infectious Diseases, Hospital Gregorio Marañón, Madrid, Spain., Richter J; Division of Hematophathology, Christian-Albrechts-University, Kiel, Germany., Klapper W; Division of Hematophathology, Christian-Albrechts-University, Kiel, Germany., Tzankov A; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Dirnhofer S; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Rosenwald A; Institute of Pathology, University of Würzburg, Würzburg, Germany., Mate JL; Department of Pathology, Hospital Germans Trias i Pujol, Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Tapia G; Department of Pathology, Hospital Germans Trias i Pujol, Institut Germans Trias i Pujol (IGTP), Universitat Autònoma de Barcelona, Badalona, Spain., Lenz P; Department of Physics, University of Marburg, Marburg, Germany., Miething C; Department of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; German Cancer Consortium (DKTK), Partner Site Freiburg, Freiburg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany., Hartmann W; Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, University Hospital Münster, Münster, Germany., Chapuy B; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany., Fend F; Institute of Pathology and Neuropathology, Eberhard Karls University of Tübingen-Comprehensive Cancer Center, University Hospital Tübingen, Tübingen, Germany., Ott G; Department of Clinical Pathology, Robert Bosch Hospital, Stuttgart, Germany., Navarro JT; Department of Hematology, ICO-Hospital Germans Trias i Pujol, Josep Carreras Leukaemia Research Institute (IJC), Universitat Autònoma de Barcelona, Badalona, Spain., Grau M; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany., Lenz G; Department of Medicine A, Department of Hematology, Oncology and Pneumology, University Hospital Münster, Münster, Germany. Georg.Lenz@ukmuenster.de.
Publikováno v:
Nature communications [Nat Commun] 2021 Aug 31; Vol. 12 (1), pp. 5183. Date of Electronic Publication: 2021 Aug 31.